Skip to content
Lower risk Drug recall · FDA · Published June 8, 2026

Asclemed Accucaine 1% Lidocaine Injection Recall: Lack of Sterility Assurance

Asclemed recalls Accucaine 1% Lidocaine injection due to lack of sterility assurance. This may cause infections if used improperly. Contact the manufacturer for details.

🇺🇸 FDA recall #D-0658-2026DrugAsclemed ›
Take action

Contact the company

Recalling firmAsclemed USA Inc.379 Van Ness Ave Ste 1403 · Torrance, CA 90501-7211
✎ GovInfoNow plain-language explainer

What happened, in plain English

Asclemed is recalling Accucaine, a 1% lidocaine injection for medical use, because it may not be sterile. This could lead to infections if the product is used. Read more at govinfonow.com/recall/31212-asclemed-accucaine-1-lidocaine-injection-recall-lack-of-sterility-assurance.

Source Summary by GovInfoNow · govinfonow.com/recall/31212-asclemed-accucaine-1-lidocaine-injection-recall-lack-of-sterility-assurance · Updated August 10, 2026 · FDA enforcement record: FDA #D-0658-2026

Cite this page

“Asclemed Accucaine 1% Lidocaine Injection Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31212-asclemed-accucaine-1-lidocaine-injection-recall-lack-of-sterility-assurance. Based on FDA recall #D-0658-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0658-2026%22&limit=1).

Why it’s dangerous

The product lacks assurance of sterility, meaning it might contain contaminants that could cause infections when injected. This is a risk during medical procedures where sterile conditions are critical.

Who’s affected

Healthcare professionals and patients who have the Accucaine kit with the specified lot numbers. Those using the product for medical procedures are most at risk.

How to tell if you have this one

Check the product label for the lot numbers listed: AE3102, 121924X2, 022525X4, 033125X1, 030426X2, 033125X2, 041725X3, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 122225X4, 010626X3, 041326X4, Exp 11/30/2026; AE5052, 041426X2, 041726X1, 051826X2, Exp 04/30/2028.

  • Brand
    Asclemed
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsNDC
D-0658-2026Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.; Lot #: AE3102, 121924X2, 022525X4, 033125X1, 030426X2, 033125X2, 041725X3, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 122225X4, 010626X3, 041326X4, Exp 11/30/2026; AE5052, 041426X2, 041726X1, 051826X2, Exp 04/30/2028.76420-715-01
D-0659-2026Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.; Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.85766-187-01, 85766-187-25
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers listed in the recall notice to determine if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Jun 8, 202612. FDA classified it Class II: Jul 2, 202623. Published in FDA’s Enforcement Report: Jul 8, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Asclemed recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0658-2026 (June 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0658-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA